The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study.
Rutkowski P, Bylina E, Klimczak A, Switaj T, Falkowski S, Kroc J, Lugowska I, Brzeskwiniewicz M, Melerowicz W, Osuch C, Mierzejewska E, Wasielewski K, Woźniak A, Grzesiakowska U, Nowecki ZI, Siedlecki JA, Limon J.
Rutkowski P, et al. Among authors: siedlecki ja.
BMC Cancer. 2012 Mar 22;12:107. doi: 10.1186/1471-2407-12-107.
BMC Cancer. 2012.
PMID: 22439647
Free PMC article.